Assert-IQ vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott

Zio AT ECG Monitoring System

by iRhythm Technologies, Inc.

AI Verdict

Assert-IQ and Zio AT ECG Monitoring System are adjacent competitors, both leveraging AI for cardiac arrhythmia detection. Assert-IQ provides long-term, continuous monitoring via a minimally invasive insertable cardiac monitor for up to six years, suitable for elusive arrhythmias. In contrast, the Zio AT system offers continuous, AI-powered ECG monitoring for up to 14 days through a non-invasive wearable patch, focusing on shorter-term, real-time data transmission. The choice between them depends on the required monitoring duration and the patient's preference for invasiveness.

Choose Assert-IQ if…

Choose Assert-IQ if your patient requires exceptionally long-term, continuous cardiac monitoring, potentially for several years, to detect rare or highly intermittent arrhythmias that might be missed by shorter-duration external monitors. This minimally invasive insertable device is ideal for patients where a definitive diagnosis has been elusive and extended, unobtrusive monitoring is critical for comprehensive arrhythmia detection and management.

View Assert-IQ →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT if your patient needs continuous, real-time ECG monitoring for up to 14 days, with a focus on immediate detection and transmission of symptomatic or asymptomatic cardiac events. This wearable system is well-suited for initial diagnostic workups or when a non-invasive, short-to-medium term solution is preferred to capture arrhythmias and provide comprehensive reports quickly.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	Zio AT ECG Monitoring System
Pricing	Unknown	Contact for pricing
Deployment	Subcutaneously implanted device with mobile app connectivity	Cloud-based (data analytics and clinician portal)
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	Zio AT ECG Monitoring System
Product Type	Insertable Cardiac Monitor (ICM)	Wearable Mobile Cardiac Telemetry (MCT) service
Company	Abbott Medical	iRhythm Technologies, Inc.
Monitoring Duration	Up to 6 years	Up to 14 days
Mobile App	None	ZioSuiteu00ae clinician portal and mobile app, MyZiou00ae patient mobile app
Key Detection Method	Advanced arrhythmia detection algorithms	FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection
Data Export	Yes	Not specified

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and Zio AT ECG Monitoring System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in how these devices monitor cardiac activity?

Assert-IQ is an Insertable Cardiac Monitor (ICM) designed for long-term, continuous monitoring for up to 6 years. The Zio AT ECG Monitoring System is a wearable mobile cardiac telemetry (MCT) service that offers continuous ECG recording for up to 14 days via a patch.

What are the key differences in monitoring duration and patient experience?

Assert-IQ provides continuous monitoring for up to 6 years and requires a minimally invasive insertion. Zio AT offers continuous monitoring for up to 14 days via a wearable patch, and includes a MyZio patient mobile app for symptom logging and education.

How do these systems transmit and provide access to patient data?

Assert-IQ uses Bluetooth Low Energy for data transmission to a secure cloud-based platform, offering remote monitoring and proactive clinician alerts. Zio AT utilizes a wireless gateway for real-time data transmission to a cloud-based clinician portal (ZioSuite) and provides comprehensive end-of-wear reports.

What are the specific AI capabilities for arrhythmia detection in each system?

Assert-IQ employs advanced arrhythmia detection algorithms. Zio AT uses an FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection, capable of detecting both symptomatic and asymptomatic cardiac events.

Do both systems offer patient engagement tools?

Yes, Assert-IQ includes a patient activator for symptom logging. Zio AT offers the MyZio patient mobile app for symptom logging and education.

What is the maximum monitoring period for each device?

Assert-IQ provides long-term continuous cardiac monitoring for up to 6 years. Zio AT offers continuous, uninterrupted ECG recording for up to 14 days.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Assert-IQ or Zio AT ECG Monitoring System

Backers

Who funded each tool's parent company.